Skip to content
healthcare.dev

Azacitidine

NDC 75907-225, Azacitidine, injection, powder, lyophilized, for solution, from Dr. Reddy's Laboratories Inc..

Product NDC
75907-225
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201537
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75907-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
75907-225-11759070225111 VIAL in 1 CARTON (75907-225-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/060d56e7-1a24-87c1-7f40-149ecf424f7c
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75907-225

Use it

Look up 75907-225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75907-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75907-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.